Author

Thomas Machnig

Observed names: Machnig, Thomas, T Machnig, T. Machnig, Thomas Machnig

Institutions: Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz

Observed institutions: Universitat Autònoma de Barcelona, Uppsala University, Guy's Hospital, University of Minnesota, Boehringer Ingelheim (Germany), Karolinska University Hospital, University of Miami, Merck KGaA, Darmstadt (Germany), Tampere University, Friedrich-Alexander-Universität Erlangen-Nürnberg, Johannes Gutenberg University Mainz, Barts Health NHS Trust, Royal Sussex County Hospital, Royal Gwent Hospital, Karolinska Institutet, University of Catania, Luigi Sacco Hospital, Universitätsklinikum Erlangen, Düsseldorf University Hospital, University Medical Center of the Johannes Gutenberg University Mainz, BioMarin (United Kingdom), Hospital La Paz Institute for Health Research, Behringwerke (Germany), CSL (United States), Centre Hospitalier de Mulhouse, Klinikum Lippe, Klinikum Kassel, CSL (Germany), Merck Healthcare KGaA, Darmstadt (Germany), BioMarin (United States), University of Lübeck

ORCID: 0000-0001-5075-2364

Observed ORCID: 0000-0001-5075-2364

OpenAlex ID: A5025683851

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

2008 · Werner Hacke, Markku Kaste, et al. · New England Journal of Medicine · 6,809

PDF

Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

2008 · Ralph L. Sacco, Hans-Christoph Diener, et al. · New England Journal of Medicine · 960

PDF

Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

2008 · Salim Yusuf, Hans-Christoph Diener, et al. · New England Journal of Medicine · 791

PDF

Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials

2008 · Nils Wahlgren, Niaz Ahmed, et al. · Stroke · 455

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study

2008 · Hans-Christoph Diener, Ralph L Sacco, et al. · The Lancet Neurology · 362

Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial

2009 · Erich Bluhmki, Ángel Chamorro, et al. · The Lancet Neurology · 347

The Na+/H+exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction11This manuscript is dedicated to the memory of Karl-Ludwig Neuhaus (1944–2000).

2001 · Uwe Zeymer, Harry Suryapranata, et al. · Journal of the American College of Cardiology · 337

PDF

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor

2017 · Hilary Longhurst, Marco Cicardi, et al. · New England Journal of Medicine · 244

PDF

C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks - final results of the I.M.P.A.C.T.2 study

2011 · T. J. Craig, A. K. Bewtra, et al. · Allergy · 145

PDF

Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial

2010 · Reinhard Dengler, Hans-Christoph Diener, et al. · The Lancet Neurology · 125

Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence

2020 · Konrad Bork, Thomas Machnig, et al. · Orphanet Journal of Rare Diseases · 121

PDF

2018 · William R. Lumry, Timothy Craig, et al. · The Journal of Allergy and Clinical Immunology In Practice · 101

Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks

2013 · Timothy J. Craig, Mikhail A. Rojavin, et al. · Annals of Allergy Asthma & Immunology · 64

Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction

2003 · Uwe Zeymer, Rolf Schröder, et al. · American Heart Journal · 46

Patient satisfaction and experience with intravenously administered C1-inhibitor concentrates in the United States

2017 · Marc A. Riedl, Aleena Banerji, et al. · Annals of Allergy Asthma & Immunology · 42

Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

2021 · William R. Lumry, Bruce Zuraw, et al. · Orphanet Journal of Rare Diseases · 41

PDF

C1‐ INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies

2012 · Lynda Schneider, David Hurewitz, et al. · Pediatric Allergy and Immunology · 39

Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen gene

2020 · Konrad Bork, Karin Wulff, et al. · Orphanet Journal of Rare Diseases · 38

PDF

Per-Attack Reporting of Prodromal Symptoms Concurrent with C1-Inhibitor Treatment of Hereditary Angioedema Attacks

2012 · Michael J. Prematta, Againdra K. Bewtra, et al. · Advances in Therapy · 37

Biochemical comparison of four commercially available C 1 esterase inhibitor concentrates for treatment of hereditary angioedema

2014 · Annette Feussner, Uwe Kalina, et al. · Transfusion · 34

PDF

Treatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: A systematic literature review

2013 · Konrad Bork, Isabella Steffensen, et al. · Allergy and Asthma Proceedings · 34

C1-inhibitor therapy for hereditary angioedema attacks: Prospective patient assessments of health-related quality of life

2012 · Againdra K. Bewtra, Robyn J. Levy, et al. · Allergy and Asthma Proceedings · 33

Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency

2016 · Konrad Bork, Jonathan A. Bernstein, et al. · Journal of Emergency Medicine · 30

PDF

Safety of C1-Esterase Inhibitor in Acute and Prophylactic Therapy of Hereditary Angioedema: Findings from the Ongoing International Berinert Patient Registry

2014 · Paula Busse, Anette Bygum, et al. · The Journal of Allergy and Clinical Immunology In Practice · 30

Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate

2023 · Marc A. Riedl, David R. Hinds, et al. · Allergy and Asthma Proceedings · 26

Works count: 101

Citation count: 11,530

H-index: 25

I10-index: 34